Biggest News Aggregation in the World
📰 Lead Optimisation News

Lead Optimisation News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Lead Optimisation. Real-time updates on events, politics, business and more.

Beta results prompt early access to AI drug design software

University of Cambridge spin-out DeepMirror, software developers for the discovery of novel therapeutic drugs, has launched an Early Access Programme after a successful closed beta programme during which chemists were invited to test the software over several months. Click to read more...
United Kingdom United States Max Jakobs Early Access Programme University Of Cambridge Boston Consulting Group

EQS-News: Proteros receives minority investment from private equity firm Inflexion

EQS-News: Proteros biostructures GmbH / Key word(s): Financing Proteros receives minority investment from private equity firm Inflexion 09.01.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Proteros receives minority investment from private equity fir...
United States United Kingdom City Of Noord Holland Houlihan Lokey Katja Arnold

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

EQS-News: Proteros biostructures GmbH: Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases

EQS-News: Proteros biostructures GmbH / Key word(s): Alliance Proteros and Adrestia initiate multi-target partnership to discover first-in-class drugs for intractable genetic diseases 25.10.2022
Switzerland General United Kingdom Nordrhein Westfalen Tom Donovan Tom Heightman Kostenloser Wertpapierhandel

Adrestia Therapeutics: Adrestia appoints Head of Chemistry and initiates multi-target partnership with Proteros to discover first-in-class drugs for intractable genetic diseases

Drug discovery leader Dr James Osborne brings strong track record of delivering drug candidates for oncology and CNS disorders Proteros selected for its cutting-edge structure-based drug
United Kingdom Switzerland General Nordrhein Westfalen Tom Donovan Tom Heightman Kostenloser Wertpapierhandel

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science